Home › Trial NCT05688605
A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors
- Trial IDNCT05688605
- StatusRecruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorLepu Biopharma Co., Ltd.
- Enrollment18
- Start date2022-06-30
- ConditionsAdvanced Solid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.